Night-shift work and risk of colorectal cancer in the Nurses' Health Study

Journal of the National Cancer Institute

Volumn 95, Issue 11, 2003, Pages 825-828

  Schernhammer, Eva S ^a,b   Laden, Francine ^a,c   Speizer, Frank E ^a,c   Willet, Walter C ^a,d   Hunter, David J ^a,e   Kawachi, Ichiro ^a,d   Fuchs, Charles S ^a,c   Colditz, Graham A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD CENTER FOR CANCER PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTESTINE CANCER; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MULTIVARIATE ANALYSIS; NIGHT WORK; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CASE CONTROL STUDY; COLORECTAL TUMOR; EPIDEMIOLOGY; HEALTH SURVEY; LIFESTYLE; METHODOLOGY; MIDDLE AGED; NURSE; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICS; TIME; UNITED STATES; WORK SCHEDULE;

ADULT; AGED; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HEALTH SURVEYS; HUMANS; LIFE STYLE; MELATONIN; MIDDLE AGED; NURSES; ODDS RATIO; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; WORK SCHEDULE TOLERANCE;

EID: 0037704257     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.11.825     Document Type: Article

References (37)

1. Czeisler CA, Dijk DJ. Chapter 20: human circadian physiology and sleep-wake regulation. In: Takahashi JS, Turek FW, Moore RY, editors. Handbook of behavioral neurobiology: circadian clocks. New York (NY): Plenum Publishing; 2001. p. 531-69.
2. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler C. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000;526:695-702.
3. Graham C, Cook MR. Examination of the melatonin hypothesis in women exposed at night to EMF or bright light. Environ Health Perspect 2001;109:501-7.
4. Cohen M, Lippman M, Chabner B. Role of pineal gland in aetiology and treatment of breast cancer. Lancet 1978;2:814-6.
5. Pukkala E, Auvinen H, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants. BMJ 1995;311:649-52.
6. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001; 12:95-101.
7. Tynes T, Hannevik M, Andersen A, Vistnes A, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996;7:197-204.
8. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-7.
9. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62.
10. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001;93:1563-8.
11. Kerenyi NA, Pandula E, Feuer GM. Oncostatic effects of the pineal gland. Drug Metabol Drug Interact 1990;8:313-9.
12. Hill SM, Blask DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988;48:6121-6.
13. Cos S, Fernandez F, Sanchez-Barcelo EJ. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 1996;58:2447-53.
14. Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998;58: 4383-90.
15. Mediavilla MD, Cos S, Sanchez-Barcelo EJ. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 1999;65:415-20.
16. Cos S, Mediavilla MD, Fernandez R, Gonzalez-Lamuno D, Sanchez-Barcelo EJ. Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 2002;32:90-6.
17. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat. Cancer Res 1981;41:4432-6.
18. Farriol M, Venereo Y, Orta X, Castellanos JM, Segovia-Silvestre T. In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line. J Appl Toxicol 2000;20: 21-4.
19. Anisimov VN, Popovich IG, Zabezhinski MA. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997;18:1549-53.
20. Anisimov VN, Kvetnoy IM, Chumakova NK, Kvetnaya TV, Molotkov AO, Pogudina NA, et al. Melatonin and colon carcinogenesis. Exp Toxicol Pathol 1999;51:47-52.
21. Anisimov VN, Popovich IG, Shtylik AV, Zabezhinski MA, Ben-Huh H, Gurevich P, et al. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine, in rats. Exp Toxicol Pathol 2000;52:71-6.
22. Vician M, Zeman M, Herichova I, Jurani M, Blazicek P, Matis P. Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery. J Pineal Res 1999;27:164-9.
23. Khoory R, Stemme D. Plasma melatonin levels in patients suffering from colorectal carcinoma. J Pineal Res 1988;5:251-8.
24. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. Dietary fat and the risk of breast cancer. N Engl J Med 1987;316:22-8.
25. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044-9.
26. Willett WC, Browne ML, Bain C, Lipnick RJ, Stampfer MJ, Rosner B, et al. Relative weight and risk of breast cancer among pre-menopausal women. Am J Epidemiol 1985; 122:731-40.
27. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997;6:49-62.
28. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, et al. Test of the National Death Index. Am J Epidemiol 1984;119:837-9.
29. Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator. Washington (DC): Government Printing Office; 1979. NIH Publ No. (PHS)79-1649.
30. Taylor PJ, Pocock SJ. Mortality of shift and day workers 1956-68. Br J Ind Med 1972; 29:201-7.
31. Rafnsson V, Gunnarsdottir H. Mortality study of fertiliser manufacturers in Iceland. Br J Ind Med 1990;47:721-5.
32. Vijayalaxmi, Thomas CR Jr, Reiter RJ, Herman TS. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002; 20:2575-601.
33. Spiegel D, Sephton S. Re: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2002;94:530.
34. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123: 894-900.
35. Laden F, Neas LM, Tolbert PE, Holmes MD, Hankinson SE, Spiegelman D, et al. Electric blanket use and breast cancer in the Nurses' Health Study. Am J Epidemiol 2000;152: 41-9.
36. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-8.
37. McMichael AJ. Standardized mortality ratios and the "healthy worker effect": scratching beneath the surface. J Occup Med 1976;18: 165-8.